Citurgia Biochemicals Limited has made a regulatory disclosure regarding the appointment of a new Chief Financial Officer.
The Board of Directors, in its meeting held on 29th May 2026, appointed Mr. Kashi Nath Jha as Chief Financial Officer & Key Managerial Personnel of the Company with effect from 29th May 2026. The appointment was made based on the recommendation of the Nomination and Remuneration Committee.
The Board Meeting commenced at 11:00 noon and concluded at 12:00 P.M. (IST).
Profile of Appointee
Mr. Kashi Nath Jha has extensive experience of 28 years in the field of Finance and Accounts. He is also an expert in conducting feasibility studies, strategic financial planning, and establishment of policies and mechanisms, P&L operations, and risk mitigation.
Additional Details
- Reason for change: Appointment of Mr. Kashi Nath Jha as Chief Financial Officer & Key Managerial Person
- Date of Appointment: May 29, 2026
- Relationships between directors: Not Applicable (as this is not a director appointment)
The company has requested BSE Limited to update their records with this information.